Opioid-Sparing Joint Replacement
Recruiting
Phase 3
Interventional Study
Pain Management
Opioid Consumption
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 120 (estimated)
- Sponsor
- Emory University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate whether an opioid-sparing postoperative pain regimen can reduce opioid consumption and maintain effective pain control in adults undergoing anterior total hip arthroplasty for osteoarthritis.
The main questions it aims to answer are:
* Does an opioid-limited regimen result in lower postoperative opioid use compared with a standard opioid prescriptio…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of hip osteoarthritis requiring primary arthroplasty
* Scheduled to undergo anterior total hip arthroplasty (THA)
* Able to comply with study procedures and follow-up visits
* Able to provide informed consent
Exclusion Criteria:
* Concurrent significant injuries to…
Contacts